Skip to content
Disclosery

ROYCE & ASSOCIATES LP: DVAX position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of ROYCE & ASSOCIATES LP on DVAX, newest first. How the timeline and the estimate are built.

ROYCE & ASSOCIATES LP held 0 DVAX shares at 2025-09-30 per its 13F-HR filed 2025-11-12.

the latest 13F is the newest step

  1. period ended2025-09-30
    13F 0 shares
    Change vs previous 13F -11,340 shares

    13F-HR 0000906304-25-000248 filed by ROYCE & ASSOCIATES LP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

    Exited: the 13F for this period no longer lists the position.

  2. period ended2025-06-30
    13F 11,340 shares
    Change vs previous 13F -226,259 shares

    <0.01% of the 13F portfolio, value $112,493.

    13F-HR 0000906304-25-000173 filed by ROYCE & ASSOCIATES LP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2025-03-31
    13F 237,599 shares
    Change vs previous 13F -125,220 shares

    0.03% of the 13F portfolio, value $3,081,659.

    13F-HR 0000906304-25-000113 filed by ROYCE & ASSOCIATES LP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2024-12-31
    13F 362,819 shares
    Change vs previous 13F -11,300 shares

    0.04% of the 13F portfolio, value $4,633,199.

    13F-HR 0000906304-25-000062 filed by ROYCE & ASSOCIATES LP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2024-09-30
    13F 374,119 shares
    Change vs previous 13F not available

    0.04% of the 13F portfolio, value $4,167,686.

    13F-HR 0000906304-24-000143 filed by ROYCE & ASSOCIATES LP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).